--- schema_type: "SoftwareApplication" entity_type: "Mobile Application" app_name: "EpiWatch - Seizure Monitor" developer_entity: "EpiWatch, Inc." bundle_id: "com.epiwatch.public" app_store_id: "6751776471" google_play_id: "com.epiwatch" category: "Medical" primary_platform: "ios" primary_monetization: "Subscription" offline_capable: false market_region: "US" platforms: "iOS & Android" app_last_updated: "2026-03-18" report_date: "2026-03-27" report_version: "1.2.3" total_reviews: 10 overall_rating: 3.9 confidence: "low" confidence_score: 0.3 data_age_days: 55 intelligence_version: 2 tags: ["medical", "subscription", "mobile app", "app review", "app analysis", "individuals", "epilepsy", "their"] canonical_url: "https://marlvel.ai/intel-report/medical/com-epiwatch-public" license: "CC-BY-NC 4.0" last_verified: "2026-04-18T01:24:26.554Z" --- # EpiWatch - Seizure Monitor App Audit > **TL;DR:** EpiWatch - Seizure Monitor is a medical app by EpiWatch, Inc., rated 3.9/5 by 10 users, available on iOS & Android. > > **Marlvel.ai App Intelligence** — Independent analysis. US Market. No publisher influence. > **Key Insight:** EpiWatch - Seizure Monitor is a medical app by EpiWatch, Inc.. ## Metadata & Market Performance - **Publisher:** EpiWatch, Inc. - **Category:** Medical - **Target Audience:** Individuals with epilepsy and their caregivers who require clinically validated, reliable monitoring and rapid alerting to improve safety and independence. - **Platforms:** iOS & Android - **Version Audited:** 1.2.3 - **Audit Date:** 2026-03-27 - **Signal Count:** 0 reviews analyzed - **Confidence:** Low (0.3/1.0) - **App Store ID (iOS):** 6751776471 - **Bundle ID:** com.epiwatch.public - **Google Play ID:** com.epiwatch - **Data Window:** Analysis based on signals collected up to 2026-03-27 ## Executive Snapshot EpiWatch is a specialized medical-grade mobile application designed to provide tonic-clonic seizure detection and caregiver alerting for Apple Watch users. By leveraging an FDA-cleared algorithm, the app positions itself as a clinical tool rather than a standard wellness tracker, requiring a U.S. clinician’s prescription for activation. The app’s core differentiator is its clinical validation and regulatory compliance. By integrating with Apple’s Family Setup, it uniquely enables independent monitoring for users who do not own a smartphone, positioning it as a vital safety service for the epilepsy community. ## App DNA (Features & Intent) - **[Differentiator] FDA-Cleared Seizure Detection:** Clinically validated algorithm for detecting tonic-clonic seizures with high accuracy - **[Differentiator] Automated Caregiver Alerting:** Sends alerts via phone call, text, and email to a caregiver network with GPS location * *User Intent:* Users want timely prompts to stay engaged without missing updates. - **[Differentiator] Family Setup Support:** Allows independent use of cellular Apple Watch for loved ones without requiring their own iPhone ## Monetization Strategy - **Model:** Subscription - **Tiers:** Monthly subscription at $19.99, Annual subscription option available - **Analysis:** The app uses a high-trust, medical-grade subscription model requiring a clinician's prescription for activation, positioning it as a professional health service. ## SWOT Analysis **Core Strengths:** - FDA-cleared status provides high user trust - Strong integration with Apple Watch hardware - Clear, high-value clinical use case **Critical Frictions:** - High barrier to entry (prescription required) - Limited platform availability - Low review volume **Growth Levers:** - International market expansion - Integration with EHR systems - Community-driven caregiver support features **Market Threats:** - Competition from native smartwatch health features - Regulatory changes - High subscription churn risk ## The "So What?" (Strategic Takeaway) {#so-what} EpiWatch - Seizure Monitor is an established medical app that is available. With a 3.9/5 rating from 10 reviews, it shows polarized user reception. **Strategic Opportunity:** While EpiWatch - Seizure Monitor benefits from fda-cleared status provides high user trust, its vulnerability lies in high barrier to entry (prescription required). A challenger could exploit this by focusing on international market expansion. **Best for:** Individuals with epilepsy and their caregivers who require clinically validated, reliable monitoring and rapid alerting to improve safety and independence. ## Key Metrics Summary | Metric | Value | | :--- | :--- | | Overall Rating | 3.9/5 | | Total Reviews | 10 | | Confidence | Low | | Pricing Model | Subscription | | Platforms | iOS & Android | | Key Features | 3 analyzed | ## Competitor Comparison | App | Rating | Sentiment | Developer | | :--- | :--- | :--- | :--- | | **EpiWatch - Seizure Monitor** (this app) | 3.9/5 | N/A | EpiWatch, Inc. | | [Vulvar Pain Algorithm](https://marlvel.ai/intel-report/medical/com-washgyn-vestibulodynia) | N/A/5 | N/A | Jennifer Lanoff | | [Total Reflexology-3D](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) | 4.0/5 | N/A | GraphicVizion | | [CardioGenetics](https://marlvel.ai/intel-report/medical/com-scd-risk-calculator) | N/A/5 | N/A | MARK EMILE PEPIN | | [ECGsource](https://marlvel.ai/intel-report/medical/com-ecgsource-applicationname) | 3.0/5 | N/A | ECGsource LLC | | [My F1rst Steps](https://marlvel.ai/intel-report/medical/com-myfirststeps-www) | 5.0/5 | N/A | My First Steps LLC | ## Company Profile - **Developer:** EpiWatch, Inc. - **Website:** [https://epiwatch.com](https://epiwatch.com) - **Social:** [Instagram](https://www.instagram.com/danny_did_foundation_) · [Facebook](https://www.facebook.com/DannyDid) · [X/Twitter](https://twitter.com/i) · [YouTube](https://www.youtube.com/watch) · [LinkedIn](https://www.linkedin.com/company/the-danny-did-foundation) ## Data Sources & Links - **App Store:** [View on Apple Store](https://apps.apple.com/us/app/epiwatch-seizure-monitor/id6751776471?uo=2) - **Google Play:** [View on Google Play](https://play.google.com/store/apps/details?id=com.epiwatch&hl=en&gl=us) - **Dev Site:** [Official Website](https://epiwatch.com) - **Sources:** Developer website content, About us / company information, App store metadata. ## Related Intel Reports - [*Vulvar Pain Algorithm*](https://marlvel.ai/intel-report/medical/com-washgyn-vestibulodynia) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Total Reflexology-3D*](https://marlvel.ai/intel-report/medical/com-acupuncturelearning-totalreflexology) (GraphicVizion) — 4.0/5 Rating | N/A Sentiment - [*CardioGenetics*](https://marlvel.ai/intel-report/medical/com-scd-risk-calculator) (MARK EMILE PEPIN) — N/A Rating | N/A Sentiment - [*ECGsource*](https://marlvel.ai/intel-report/medical/com-ecgsource-applicationname) (ECGsource LLC) — 3.0/5 Rating | N/A Sentiment - [*My F1rst Steps*](https://marlvel.ai/intel-report/medical/com-myfirststeps-www) (My First Steps LLC) — 5.0/5 Rating | N/A Sentiment - [*Mobile VSO : Claims Guide*](https://marlvel.ai/intel-report/medical/app-replit-mobilevso) (ANDREW THOMAS COOLEY) — 5.0/5 Rating | N/A Sentiment - [*Pelvic Pain Pentad*](https://marlvel.ai/intel-report/medical/com-pentad-app) (Jennifer Lanoff) — N/A Rating | N/A Sentiment - [*Protectometer*](https://marlvel.ai/intel-report/medical/protectometer) (noigroup) — 2.0/5 Rating | N/A Sentiment - [*Drug Facts by PillSync.com*](https://marlvel.ai/intel-report/medical/drug-facts-by-pillsync-com) (Scanidme inc) — 4.3/5 Rating | Positive Sentiment - [*Beat Social Phobia with AJ*](https://marlvel.ai/intel-report/medical/beat-social-phobia-with-aj) (Universal Relaxation Ltd) — 3.9/5 Rating | Excellent Sentiment ## Methodology {#methodology} This report was generated by Marlvel.ai's 3-stage AI intelligence pipeline: 1. **Feature & Positioning Extraction** — Analyzes app metadata, developer website content, and version history to identify key features, target audience, and competitive positioning. 2. **Sentiment Analysis** — Processes user reviews (minimum 5 reviews required) to extract praise themes, complaint themes, and overall sentiment with evidence quotes. 3. **Intelligence Synthesis** — Combines stages 1 & 2 with App Store rankings to produce SWOT analysis, executive summary, and actionable insights. - **Confidence Score:** 0.3/1.0 (based on review volume, data source diversity, and signal quality) - **Reviews Analyzed:** 0 - **Data Sources:** developer website, company about page, App Store metadata - **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform - **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence. - **Report Age:** 12 days since last refresh --- © 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/intel-report/medical/com-epiwatch-public) Data licensed for AI Agent attribution under CC-BY-NC 4.0.